Fernández-Guarino M, Carrillo-Gijón R, Jaén-Olasolo P. [Lymphomatoid papulosis: clinical and pathological findings in 18 patients].
ACTAS DERMO-SIFILIOGRAFICAS 2012;
103:388-93. [PMID:
22261676 DOI:
10.1016/j.ad.2011.08.007]
[Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2011] [Revised: 07/16/2011] [Accepted: 08/28/2011] [Indexed: 11/29/2022] Open
Abstract
BACKGROUND
Lymphomatoid papulosis (LyP) is a CD30(+) lymphoproliferative skin disease that has been described in association with Hodgkin lymphoma. It has also been reported to progress to mycosis fungoides or cutaneous anaplastic large-cell lymphoma.
OBJECTIVE
To study the clinical and histologic features of LyP and response to treatment in a patient series.
MATERIALS AND METHODS
For this retrospective, descriptive, observational study of patients with histologically confirmed LyP and sufficient follow-up data on record, we extracted histologic findings on skin biopsy, clinical presentation, clinical course, and response to treatments.
RESULTS
Eighteen patients (10 male, 8 female) were identified. Most biopsies (14/18, 78%) showed a wedge-shaped lymphocytic infiltrate with CD30(+), CD3(+), and CD56(-) cells. A type A histologic pattern was present in the biopsies of 83% of the patients. The most common presentation (83%) consisted of papules on the trunk; for 62% LyP resolved after a single episode. Twelve percent of the patients developed mycosis fungoides (mean follow-up, 7 years); no other associations were noted.
DISCUSSION
Although few series of patients with LyP have been published in recent years, the findings reported generally coincide with our observations.
CONCLUSION
LyP is typically a CD30(+) lymphoproliferative disorder that usually runs a benign course and responds well to treatment.
Collapse